Case Study

Harnessing Data Intelligence to Assess Launch Readiness

Vivian Lee

Managing Director

Pratna Ramachandran

Engagement Manager

Focus Area/Service

Life Sciences Advisory

How a Leading Life Sciences and Pharmaceutical Company Transformed Complex Pre-Launch Data into Actionable Insights

Client Overview

Industry: Life Sciences, Pharmaceutical
Focus: Commercial Precision Medicine and Diagnostics
Scope: Global operations across 5 regions and 3 therapeutic areas

Behind every drug launch lies a sea of countless pre-launch activities. Each activity’s outcome influences the success of the launch, and navigating this complex journey demands both accuracy and foresight. In a process that spans years, having the right data at the right moment isn’t just about efficiency — it’s about delivering hope and treatments to patients in need sooner.

A global pharmaceutical leader’s commercial precision medicine division faced this challenge. As its portfolio of targeted precision medicine therapies grew, so did the complexity of planning and managing launches with diagnostic testing across markets. The company needed more than just data tracking — it needed a strategic command center that could illuminate launch risks, identify opportunities, and drive informed decision-making across its expanding portfolio and global footprint.

The Challenge: Optimize Launch Readiness

As the organization expanded its precision medicine portfolio, teams executed critical pre-launch activities worldwide, but leaders lacked the real-time visibility needed to make confident decisions about launch readiness and resource allocation. This created several challenges:

Lack of centralized monitoring capabilities to assess pre-launch investments
Difficulty tracking critical value drivers and leading indicators
Limited visibility into cross-regional trends and anomalies
Inefficient manual tracking of diagnostic landscape and market metrics
Complex coordination across multiple therapeutic areas

To address these obstacles, the company needed a strategic partner who could combine deep industry expertise with technical capabilities to create a sustainable monitoring solution.

A Strategic Approach to Dashboard Development

Acquis approached this challenge with a process designed to create not just a dashboard, but a strategic decision-making tool. Through collaborative stakeholder workshops, interviews, and Acquis’ industry expertise, Acquis helped the client prioritize and define the most critical metrics for their precision medicine launches — translating deep industry expertise into a customized measurement framework.

Detailed conversations with the client produced key questions that shaped the dashboard design, including:

How can we optimize the identification of eligible patients throughout the precision medicine journey?
What’s the best way to balance varying data availability across therapeutic areas and regions?
How can we effectively show progress given different maturity levels and data availability across therapeutic areas, regions, and countries?
What leading pre-launch success metrics will best inform proactive decision-making?

Building the Command Center: Five Strategic Pillars

Based on stakeholder insights and prioritized metrics, Acquis developed a comprehensive dashboard wireframe around five key pillars:

Testing Landscape: Providing comprehensive visibility into testing rates and trends.

Operational Readiness: Measuring healthcare provider awareness and testing willingness to identify potential launch bottlenecks.

Access: Tracking critical metrics to measure a patient’s physical and financial testing accessibility.

Advocacy: Monitoring partner activities, activation progress, and engagement across different initiatives to optimize collaborative efforts.

Lab Testing Maturity: Tracking the accuracy of lab test interpretation and its turnaround time.

The Power of Strategic Visibility

Each metric was rigorously evaluated and selected based on two strategic criteria: its impact on business outcomes and launch success, and the degree to which the organization could influence results through focused investments and interventions. This dual framework ensured the dashboard would track important and actionable metrics that could guide strategic decision-making.

At the heart of the dashboard’s effectiveness is its ability to translate complex launch data into clear, actionable intelligence. Through carefully designed visualizations and interactive features, leaders can quickly assess launch readiness and uncover key insights through:

Interactive filtering by region, therapeutic area, and operating company
Visual representations of key metrics for quick executive decision-making
Real-time tracking of critical success factors
Comprehensive view of the testing-to-treatment journey

Impact and Value Creation

The dashboard delivers multiple layers of value:

Immediate Benefits:

Enhanced investment decision-making through real-time insights
Improved operational efficiency via centralized monitoring
Reduced manual tracking of critical pre-launch diagnostic metrics
Optimized cross-functional coordination

Strategic Advantages:

Accelerated market readiness assessment
More efficient resource allocation
Improved global launch synchronization

More Than Data Visualization

What began as a visibility challenge evolved into a powerful strategic asset for accelerating precision medicine launches worldwide. Acquis’ solution offered the organization a way to optimize operations, make intelligent business decisions, and, most importantly, bring life-changing therapies to patients faster.

In the race to deliver precision medicine therapies, every moment saved in the launch process represents hope for patients waiting for treatment. By transforming data into actionable intelligence, this dashboard not only bridges the gap between innovation and patient care but enables the accelerated delivery of breakthrough therapies to those who need them most.

Curious what Acquis Life Sciences can do for you? Reach out →